BTCY (Biotricity) Cyclically Adjusted PB Ratio: (As of Jul. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BTCY Biotricity Inc BTCY
21 GF Score
Price $0.11
GF Value $0.39
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Biotricity Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Biotricity  (OTCPK:BTCY) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Biotricity Cyclically Adjusted PB Ratio Related Terms


Biotricity Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Biotricity's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotricity Cyclically Adjusted PB Ratio Chart

Biotricity Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Biotricity Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BTCY vs FEED, LUDG, USAQ: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, Biotricity's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotricity Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biotricity's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Biotricity's Cyclically Adjusted PB Ratio falls into.


BTCY
21GF Score
Biotricity Inc BTCY
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biotricity Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Biotricity's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, Biotricity's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book=Book Value per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-1.206/330.2130*330.2130
=-1.206

Current CPI (Mar. 2026) = 330.2130.

Biotricity Quarterly Data

Book Value per Share CPI Adj_Book
201606 -0.881 241.018 -1.207
201609 -0.576 241.428 -0.788
201612 -0.930 241.432 -1.272
201703 -0.967 243.801 -1.310
201706 -0.701 244.955 -0.945
201709 -0.019 246.819 -0.025
201712 0.370 246.524 0.496
201803 0.033 249.554 0.044
201806 -0.134 251.989 -0.176
201809 -0.113 252.439 -0.148
201812 -0.148 251.233 -0.195
201903 -0.302 254.202 -0.392
201906 -0.553 256.143 -0.713
201909 -0.814 256.759 -1.047
201912 -0.316 256.974 -0.406
202003 -0.495 258.115 -0.633
202006 -0.805 257.797 -1.031
202009 -1.194 260.280 -1.515
202012 -1.700 260.474 -2.155
202103 -1.051 264.877 -1.310
202106 -1.618 271.696 -1.966
202109 0.951 274.310 1.145
202112 0.280 278.802 0.332
202203 -0.251 287.504 -0.288
202206 -0.762 296.311 -0.849
202209 -1.228 296.808 -1.366
202212 -1.778 296.797 -1.978
202303 -2.267 301.836 -2.480
202306 -2.675 305.109 -2.895
202309 -3.034 307.789 -3.255
202312 -2.946 306.746 -3.171
202403 -3.307 312.332 -3.496
202406 -1.376 314.175 -1.446
202409 -1.354 315.301 -1.418
202412 -1.301 315.605 -1.361
202503 -1.220 319.799 -1.260
202506 -1.227 322.561 -1.256
202509 -1.240 324.800 -1.261
202512 -1.224 324.054 -1.247
202603 -1.206 330.213 -1.206

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Biotricity (BTCY) Overvalued in 2026?

Based on GuruFocus' analysis, Biotricity stock appears to be undervalued. The current stock price of $0.11 is trading 71.7% below its estimated GF Value™ of $0.39. GuruFocus considers Biotricity to be Possible Value Trap.

Key valuation signals for BTCY:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: $0.39 vs. price of $0.11 (71.7% below fair value)
  • GF Score™: 21/100 with 7 warning signs

No single metric tells the full story. See the BTCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Biotricity Business Description

Address 203 Redwood Shores Parkway, Suite 600, Redwood City, CA, USA, 94065
Biotricity Inc is a medical technology company that focuses on biometric data monitoring solutions. It aims to deliver remote monitoring solutions to the healthcare & consumer markets, with a focus on diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. Biotricity is expanding medical-grade monitoring into the consumer market via its Biolife solution, which empowers users to self-manage chronic conditions. Its products include Bioflux, which is a mobile cardiac telemetry (MCT) device that provides real-time monitoring and transmission of ambulatory patients' ECG information; Biocare Telemed; Bioheart, which is a personal heart monitor; Biokit, and Biocare health.
21GF Score

Get the complete analysis for BTCY

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.11
Price
$0.39
GF Value